Sequential and simultaneous dual-isotope brain SPECT: Comparison with PET for estimation and discrimination tasks in early Parkinson disease

Medical Physics

Volumn 35, Issue 7, 2008, Pages 3343-3353

  Trott, Cathryn M ^a   El Fakhri, Georges ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Activity and size estimation; Cramer Rao bound; Parkinson disease; Simultaneous dual isotope SPECT

Indexed keywords

BIOINFORMATICS; CAMERAS; CRAMER-RAO BOUNDS; FLIGHT SIMULATORS; MEDICAL IMAGING; MONTE CARLO METHODS; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPES; SCANNING; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ACTIVITY CONCENTRATION; AREA UNDER THE ROC CURVE; DISCRIMINATION ACCURACY; PARKINSON DISEASE; PHYSIOLOGICAL CONDITION; SIMULTANEOUS DUAL-ISOTOPE SPECT; SIZE ESTIMATION; THEORETICAL PERFORMANCE;

BRAIN;

ALTROPANE; CARBON 11; DOPAMINE TRANSPORTER; IODINE 123; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; RADIOISOTOPE; TECHNETIUM 99M; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M;

AREA UNDER THE CURVE; ARTICLE; COLLIMATOR; CORPUS STRIATUM; DEVICE; DISCRIMINANT ANALYSIS; MONTE CARLO METHOD; NEUROTRANSMISSION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTILLATION CAMERA; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 46149123704     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2940605     Document Type: Article

References (29)

1. S. Asenbaum, T. Brucke, W. Pirker, I. Podreka, P. Angelberger, S. Wenger, C. Wber, C. Mller, and L. Deecke, " Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.," J. Nucl. Med. 38, 1-6 (1997). 0161-5505
2. K. Marek, R. Innis, C. van Dyck, B. Fussell, M. Early, S. Eberly, D. Oakes, and J. Seibyl, " [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.," Neurology 57, 2089-2094 (2001). 0028-3878
3. A. J. Fischman, A. A. Bonab, J. W. Babich, E. P. Palmer, N. M. Alpert, D. R. Elmaleh, R. J. Callahan, S. A. Barrow, W. Graham, P. C. Meltzer, R. N. Hanson, and B. K. Madras, " Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters.," Synapse 0887-4476 10.1002/(SICI)1098-2396(199806)29:2<128::AID-SYN4>3.0.CO;2-9 29, 128-141 (1998).
4. 123I imaging in estimation of striatal activity.," Proceedings of 2003 IEEE Nuclear Science Symposium and Medical Imaging Conference, Portland, Oregon, 2003.
5. H. van Trees, Detection, Estimation and Modulation Theory, Part II (Wiley, New York, 1968).
6. 123I-FP-CIT SPECT in Parkinsons disease and multiple system atrophy.," Eur. J. Nucl. Med. 33, 87-92 (2006). 0340-6997
7. C. E. Metz, " ROC methodology in radiologic imaging.," Invest. Radiol. 0020-9996 10.1097/00004424-198609000-00009 21, 720-733 (1986).
8. M. F. Kijewski, S. C. Moore, H. Jadvar, R. E. Zimmerman, and S. P. Muller, " Effects of SPECT collimation and system geometry on classification tasks related to Parkinson's disease.," IEEE Trans. Nucl. Sci. 0018-9499 10.1109/23.940155 48, 734-738 (2001).
9. G. El Fakhri, M. F. Kijewski, K. A. Johnson, G. Syrkin, R. J. Killiany, J. A. Becker, R. E. Zimmerman, and M. S. Albert, " MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease.," Arch. Neurol. 60, 1066-1072 (2003). 0003-9942
10. G. El Fakhri, M. F. Kijewski, M. S. Albert, K. A. Johnson, and S. C. Moore, " Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease.," J. Nucl. Med. 45, 2026-2031 (2004). 0161-5505
11. A. A. Bonab, A. J. Fischman, and N. M. Alpert, " Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT.," J. Nucl. Med. 41, 1086-1092 (2000). 0161-5505
12. 99mTc]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease.," Nucl. Med. Commun. 22, 151-154 (2001). 0143-3636
13. D. -Y. Geng, Y. -X. Li, and C. -S. Zee, " Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.," Neurosurgery 58, 256-262 (2006). 0148-396X
14. G. El Fakhri, M. F. Kijewski, and S. C. Moore, " Absolute activity quantitation from projections using an analytical approach: Comparison with iterative methods in Tc-99m and I-123 brain SPECT.," IEEE Trans. Nucl. Sci. 0018-9499 10.1109/23.940161 48, 768-773 (2001).
15. M. Koyama, R. Kawashima, H. Ito, S. Ono, S. Kazunori, R. Goto, S. Kinomura, S. Yoshioka, T. Sato, and H. Fukuda, " SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.," J. Nucl. Med. 38, 587-592 (1997). 0161-5505
16. N. P. Verhoeff, O. Kapacu, E. Sokole-Busemann, E. Van Royen, and A. G. Janssen, " Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: Technical and intero-berserver.," J. Nucl. Med. 34, 2076-2084 (1993). 0161-5505
17. G. El Fakhri, S. C. Moore, P. Maksud, A. Aurengo, and M. F. Kijewski, " Absolute activity quantitation in simultaneous I-123/Tc-99m brain SPECT.," J. Nucl. Med. 42, 300-308 (2001). 0161-5505
18. S. Surti, A. Kuhn, M. E. Werner, A. E. Perkins, J. Kolthammer, and J. S. Karp, " Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight capabilities.," J. Nucl. Med. 48, 471-480 (2007). 0161-5505
19. R. L. Harrison, D. R. Haynor, S. B. Gillispie, S. D. Vannoy, M. S. Kaplan, and T. K. Lewellen, " A public-domain simulation system for emission tomography: Photon tracking through heterogeneous attenuation using importance sampling.," J. Nucl. Med. 34 (5), 60 (1993). 0161-5505
20. B. Gúrin and G. El Fakhri, " Realistic PET Monte-Carlo simulation with pixelated block detectors, light sharing, random coincidences and dead-time modeling.," IEEE Trans. Nucl. Sci. (in press).
21. G. V. Sawle, E. D. Playford, D. J. Brooks, N. Quinn, and R. S. J. Frackowiak, " Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism. Diagnostic implications of the D2 receptor status.," Brain 116, 853-867 (1993). 0006-8950
22. H. F. Kung, H. -J. Kim, M. -P. Kung, S. K. Meegalla, K. Plossl, and H. K. Lee, " Imaging of dopamine transporters in humans with technetium-99m TRODAT 1.," Eur. J. Nucl. Med. 23, 1527-1530 (1996). 0340-6997
23. 99mTc]TRODAT-1: A dopamine transporter imaging agent.," J. Nucl. Med. 40, 150-158 (1999). 0161-5505
24. 123I-FP-CIT SPECT study.," Eur. J. Nucl. Med. 34, 502-507 (2007). 0340-6997
25. 99mTc-TRODAT-1 imaging.," J. Nucl. Med. 42, 1303-1308 (2001). 0161-5505
26. K. V. Mardia, J. T. Kent, and J. M. Bibby, Multivariate Analysis (Academic, London, 1979).
27. 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.," Synapse 62, 62-69 (2008). 0887-4476
28. 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.," J. Nucl. Med. 45, 207-213 (2004). 0161-5505
29. 123I SPECT imaging.," Med. Phys. 0094-2405 10.1118/1.2756601 34, 3263-3272 (2007).